欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4617/001
药品名称Aciclovir Accord 25 mg/ml concentrate for solution for infusion
活性成分
    • Aciclovir 25.0 mg
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare S.L.U.
参考成员国 - 产品名称Netherlands (NL)
Aciclovir Accord 25 mg/ml concentraat voor oplossing voor infusie
互认成员国 - 产品名称
    • Iceland (IS)
    • Germany (DE)
      Aciclovir Accord 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Austria (AT)
      Aciclovir Accord 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
      Aciclovir Accord
    • Finland (FI)
    • Poland (PL)
      Aciclovir Accord
    • Lithuania (LT)
      Aciclovir Accord 25 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      ACICLOVIR ACCORD
    • Bulgaria (BG)
      Aciclovir Accord
    • Cyprus (CY)
      Aciclovir Accord 25mg/ml Concentrate for solution for infusion
    • Czechia (CZ)
      Aciclovir Accord
    • Romania (RO)
      ACICLOVIR ACCORD 25mg/ml concentrat pentru solutie perfuzabila
    • Slovenia (SI)
      Aciklovir Accord 25 mg/ml koncentrat za raztopino za infundiranje
许可日期2020/03/19
最近更新日期2025/09/28
药物ATC编码
    • J05AB01 aciclovir
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase